Back to top

Cytokinetics (CYTK) Receives a Buy from Morgan Stanley

In a report released today, Maxwell Skor from Morgan Stanley assigned a Buy rating to Cytokinetics, with a price target of $103.00. Skor covers the...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cytokinetics, Incorporated (CYTK)